Vodobatinib
目录号: A22504
Bcr-Abl1 抑制剂
Vodobatinib,也被称为 K-0706,是一种新型的第三代(3G)TKI,对野生型和突变型 BCR-ABL1 有效,且具有有限的非靶点活性。
Bcr-Abl1 抑制剂
Discription | Vodobatinib, also known as K-0706, is a novel 3rd generation (3G) TKI effective against wild-type and mutated BCR-ABL1 with limited off-target activity. |
---|
目录号 | A22504 |
---|---|
分子式 | C27H20ClN3O2 |
分子量 | 453.926 |
CAS号 | 1388803-90-4 |
SMILES | CC1=C(C=C(C(NNC(C2=C(Cl)C=CC=C2C)=O)=O)C=C1)C#CC(C=N3)=CC4=C3C=CC=C4 |
其他名称 | Vodobatinib, K-0706, K0706, K0706, |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2